
Developments in Biologicals / Advancing Science and Elimination of the Use of Laboratory Animals for Development and Control of Vaccines and Hormones
Symposium, Utrecht, November 2001, Proceedings.
Karger, S (Publisher)
1st Edition
Published in January 2003
Book
Paperback/Softback
XII, 344 pages
978-3-8055-7509-6 (ISBN)
Description
Animal experimentation plays a major role in the development and control of biological products and large numbers of animals are used for routine batch control. During the past few years considerable attention has been paid to the concept of replacing, reducing and refining (the three Rs) the use of animals for this purpose. This volume contains the proceedings of an international meeting held in Utrecht in November 2001 in which the problems associated with applying the three Rs were discussed. Particular emphasis was given to the validation and regulatory acceptance of in vitro methods and new concepts of quality control. Those issues are important for the scientific community at large as well as manufacturers, regulatory authorities and everyone concerned with animal welfare.
More details
Series
Edition
1., Aufl.
Language
English
Place of publication
Basel
Switzerland
Target group
College/higher education
Professional and scholarly
Illustrations
54
90 s/w Abbildungen, 54 s/w Tabellen
90 fig., 54 tab.; 90 Illustrations
Dimensions
Height: 24 cm
Width: 17 cm
Weight
687 gr
ISBN-13
978-3-8055-7509-6 (9783805575096)
Schweitzer Classification
Content
Opening Session: Progress in Applying the Three Rs of Russell & Burch to the Testing of Biological Products, M. Balls, M. Halder; Regulatory Processes and Three Rs Alternatives, J. Milstien. The Three Rs and Safety Testing - Current Activities, Chair P. Van der Valk; Potency Testing and the Three Rs - Current Activities, Chair I. Claassen; Testing of Hormones, Chair J. Mulders; Other Biologicals, Chair K. Weisser; Ongoing Validation Studies - Case Reports, Chair L. Bruckner; Implementation of Three Rs Alternatives in Regulatory Testing - Possibilities and Obstacles, Chair D. Stainer; Replacement in Vaccine Production and the Use of Serum Free Media, Chair C. Beuvery; New Approaches in Vaccines Development and in Vaccine Quality Control, Chair P.P. Pastoret; New Quality Control Techniques, Chair H. Kreeftenberg.